Metropolitan Life Insurance CO Ab Cellera Biologics Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $9,656 - $14,768	-1,321 Reduced 10.23%	11,589 $87,000
Q4 2022 Jun 14, 2023	BUY	$9.48 - $14.52 $12,523 - $19,180	1,321 Added 11.4%	12,910 $131 Million
Q4 2022 Mar 30, 2023	BUY	$9.48 - $14.52 $2,256 - $3,455	238 Added 1.88%	12,910 $130,000
Q4 2022 Feb 15, 2023	BUY	$9.48 - $14.52 $2,256 - $3,455	238 Added 1.88%	12,910 $130,000
Q3 2022 Jun 14, 2023	BUY	$9.2 - $13.68 $9,963 - $14,815	1,083 Added 9.35%	12,672 $125 Million
Q2 2022 Jun 20, 2023	BUY	$5.72 - $10.65 $6,194 - $11,533	1,083 Added 9.35%	12,672 $134,000
Q2 2022 Mar 30, 2023	SELL	$5.72 - $10.65 $1,361 - $2,534	-238 Reduced 1.84%	12,672 $134,000
Q2 2022 Aug 11, 2022	BUY	$5.72 - $10.65 $72,483 - $134,956	12,672 New	12,672 $135,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.